People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.

Hims & Hers (NYSE: HIMS) stock was a heartening comeback story on Wednesday, following something of a rout earlier in the ...

Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments.